Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort

被引:7
|
作者
Lammi, Matthew R. [1 ]
Saketkoo, Lesley A. [2 ]
Gordon, Jessica K. [3 ]
Lauto, Paula [1 ]
Fagan, Karen [4 ]
Steen, Virginia D. [5 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Pulm Crit Care & Allergy Immunol, New Orleans, LA USA
[2] Tulane Univ, Sch Med, Sect Pulm Dis Crit Care & Environm Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[3] Hosp Special Surg, Dept Rheumatol, 535 E 70th St, New York, NY 10021 USA
[4] Univ S Alabama, Pulm & Crit Care, Mobile, AL USA
[5] Georgetown Univ, Div Rheumatol, Washington, DC USA
基金
美国国家卫生研究院;
关键词
diastolic dysfunction; pulmonary hypertension; scleroderma; systemic sclerosis; treatment; 6-MINUTE WALK TEST; VENTRICULAR DIASTOLIC DYSFUNCTION; HEART-FAILURE; OUTCOMES; RECOGNITION; PREVALENCE; PROGNOSIS; GRADIENT; DISEASE; MARKER;
D O I
10.1111/resp.13067
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: Systemic sclerosis (SSc) is a complex autoimmune disease commonly associated with pulmonary hypertension (PH). When associated with elevated pulmonary artery wedge pressure (PAWP), pulmonary artery pressure (PAP) is either inproportion (post-capillary PH) or higher than expected (combined PH) relative to the increased PAWP. Methods: Patients from the PHAROS registry (a prospective observational cohort of SSc-PH patients) who had mean PAP >= 25 and PAWP > 15 on right heart catheterization were stratified based on diastolic pressure gradient (DPG). Kaplan-Meier analysis was performed to compare survival and PH-related hospitalization. Baseline factors were compared between patients dying and those who survived using Cox regression analysis. Results: A total of 59 patients were included, of whom 21 (36%) patients were classified as combined PH and 38 (64%) had post-capillary PH. No baseline characteristics were significantly different between the two groups. There were no differences in survival or PHrelated hospitalization between the groups. The only baseline factor independently associated with death was lower 6-min walk distance (6MWD) (hazard ratio (HR): 1.33 per 25 m decrease, 95% CI: 1.11-1.59, P = 0.002). PH-specific medications were started during follow-up in significantly more patients in the combined PH group compared with the post-capillary group (86% vs 50%, P = 0.01). Conclusion: Outcomes were similar between SSc patients with post-capillary PH and combined pre- and post-capillary PH. 6MWD at baseline can predict risk for death in SSc patients with PH and an elevated PAWP. More patients with combined PH were started on PH-specific medications, and the clinical benefit of treating this subgroup specifically in SSc patients needs further exploration.
引用
收藏
页码:1386 / 1392
页数:7
相关论文
共 50 条
  • [21] Prediction of Pulmonary Hypertension Related to Systemic Sclerosis by an Index Based on Simple Clinical Observations
    Meune, Christophe
    Avouac, Jerome
    Airo, Paolo
    Beretta, Lorenzo
    Dieude, Philippe
    Wahbi, Karim
    Caramaschi, Paola
    Tiev, Kiet
    Cappelli, Susanna
    Diot, Elisabeth
    Vacca, Alessandra
    Cracowski, Jean-Luc
    Sibilia, Jean
    Kahan, Andre
    Matucci-Cerinic, Marco
    Allanore, Yannick
    ARTHRITIS AND RHEUMATISM, 2011, 63 (09): : 2790 - 2796
  • [22] Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study
    Yuan, Yu-Ping
    Yuan, Ping
    Su, Yi-Liang
    Jiang, Rong
    Zhang, Rui
    He, Jing
    Qiu, Hong-Ling
    Luo, Ci-Jun
    Liu, Jin-Ming
    Gong, Su-Gang
    Wang, Lan
    Zhao, Qin-Hua
    CLINICAL RHEUMATOLOGY, 2022, 41 (06) : 1675 - 1686
  • [23] Pulmonary arterial hypertension in Saudi patients with systemic sclerosis: Clinical and hemodynamic characteristics and mortality
    Al Otair, Hadil A. K.
    Idrees, Majdy M.
    Saleemi, Sarfraz A.
    Eltoukhy, Ahmed M.
    Alhijji, Ali A.
    Al Habeeb, Waleed A.
    Omair, Mohammed A.
    ANNALS OF THORACIC MEDICINE, 2019, 14 (01) : 83 - 89
  • [24] Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity
    Sangani, Ruchika A.
    Lui, Justin K.
    Gillmeyer, Kari R.
    Trojanowski, Marcin A.
    Bujor, Andreea M.
    LaValley, Michael P.
    Klings, Elizabeth S.
    PULMONARY CIRCULATION, 2022, 12 (04)
  • [25] Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS)
    Kolstad, Kathleen D.
    Li, Shufeng
    Steen, Virginia
    Chung, Lorinda
    CHEST, 2018, 154 (04) : 862 - 871
  • [26] Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis
    Dimitroulas, Theodoros
    Giannakoulas, Georgios
    Papadopoulou, Klio
    Sfetsios, Tilemahos
    Karvounis, Haralambos
    Dimitroula, Hariklia
    Parcharidou, Despina
    Koliakos, Georgios
    Garyfallos, Alexandros
    Styliadis, Ioannis
    Settas, Loukas
    CLINICAL RHEUMATOLOGY, 2010, 29 (09) : 957 - 964
  • [27] Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort
    Sujau, Ibrahim
    Ng, Chin Teck
    Sthaneshwar, Pavai
    Sockalingam, Sargunan
    Cheah, Tien Eang
    Yahya, Fariz
    Jasmin, Raja
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (04) : 459 - 465
  • [28] Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease
    Launay, David
    Humbert, Marc
    Berezne, Alice
    Cottin, Vincent
    Allanore, Yannick
    Couderc, Louis-Jean
    Bletry, Olivier
    Yaici, Azzedine
    Hatron, Pierre-Yves
    Mouthon, Luc
    Le Pavec, Jerome
    Clerson, Pierre
    Hachulla, Eric
    CHEST, 2011, 140 (04) : 1016 - 1024
  • [29] Incidence, predictors, and survival of pulmonary hypertension determined by echocardiography in Thai patients with early systemic sclerosis (SSc): inception cohort study
    Wangkaew, Suparaporn
    Pota, Panupong
    Prasertwittayakij, Narawudt
    Phrommintikul, Arintaya
    CLINICAL RHEUMATOLOGY, 2021, 40 (03) : 973 - 980
  • [30] Incidence, predictors, and survival of pulmonary hypertension determined by echocardiography in Thai patients with early systemic sclerosis (SSc): inception cohort study
    Suparaporn Wangkaew
    Panupong Pota
    Narawudt Prasertwittayakij
    Arintaya Phrommintikul
    Clinical Rheumatology, 2021, 40 : 973 - 980